Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma.
Rocío Díaz AcedoSilvia Artacho CriadoEduardo Ríos HerranzAntonio Gutiérrez PizarrayaIrene Sánchez RomeroEsther Márquez SaavedraPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Hypogammaglobulinemia appears in a high percentage of patients with follicular lymphoma in a real-world population, identifying a high-risk FLIPI score as a risk factor for its development and basal gamma globulins as a protective factor.
Keyphrases